IN2013MU03373A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03373A
IN2013MU03373A IN3373MU2013A IN2013MU03373A IN 2013MU03373 A IN2013MU03373 A IN 2013MU03373A IN 3373MU2013 A IN3373MU2013 A IN 3373MU2013A IN 2013MU03373 A IN2013MU03373 A IN 2013MU03373A
Authority
IN
India
Prior art keywords
compositions
budesonide
controlled release
relates
processes
Prior art date
Application number
Other languages
English (en)
Inventor
Sushrut Krishnaji Kulkarni
Ajaykumar Handa
Pushpendra Pratap Singh
Ankur Paresh Shah
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN3373MU2013 priority Critical patent/IN2013MU03373A/en
Priority to US14/520,634 priority patent/US20150118296A1/en
Publication of IN2013MU03373A publication Critical patent/IN2013MU03373A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN3373MU2013 2013-10-25 2013-10-25 IN2013MU03373A (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3373MU2013 IN2013MU03373A (ko) 2013-10-25 2013-10-25
US14/520,634 US20150118296A1 (en) 2013-10-25 2014-10-22 Controlled release budesonide compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3373MU2013 IN2013MU03373A (ko) 2013-10-25 2013-10-25

Publications (1)

Publication Number Publication Date
IN2013MU03373A true IN2013MU03373A (ko) 2015-07-17

Family

ID=52995730

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3373MU2013 IN2013MU03373A (ko) 2013-10-25 2013-10-25

Country Status (2)

Country Link
US (1) US20150118296A1 (ko)
IN (1) IN2013MU03373A (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2018111690A (ru) 2015-09-11 2019-10-11 Сан Фармасьютикл Индастриз Лтд. Пероральная лекарственная форма будесонида
CN109999201B (zh) * 2019-04-19 2023-02-17 成都中医药大学 一种掩味伴侣剂及其用途
CN110507627B (zh) * 2019-09-29 2021-11-02 重庆医药高等专科学校 一种布地奈德的口服控释药物组合物
US11013748B2 (en) * 2019-10-03 2021-05-25 University of Nizwa Budesonide prodrug
CN110585164A (zh) * 2019-10-08 2019-12-20 苏州弘森药业股份有限公司 一种艾司奥美拉唑镁碳酸氢钠胶囊的制作方法
WO2022254456A1 (en) * 2021-06-01 2022-12-08 Nbi Biosciences Pvt Ltd Microbial-triggered oral intestinal drug delivery formulation and method of preparation thereof
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
US8895064B2 (en) * 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US7431943B1 (en) * 1999-06-14 2008-10-07 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical compositions
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets

Also Published As

Publication number Publication date
US20150118296A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
EP3349783C0 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
IN2013MU03373A (ko)
TW201613901A (en) New compounds
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12016501122A1 (en) Delayed release compositions of linaclotide
IN2015MN00478A (ko)
IN2014MN02049A (ko)
MX2017001971A (es) Composiciones antimetanogenicas y sus usos.
MD20170048A2 (ro) Formulare pe bază de acetat de abirateronă şi procedee de utilizare a acesteia
PL3240550T3 (pl) Kombinacja glikozaminoglikanów i środka zobojętniającego kwas i ich kompozycje
EP2986316A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND / OR PROPHYLAXIS OF A DIFFICULT CLOSTRIDIUM ASSOCIATED DISEASE
IN2013MU03641A (ko)
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
IN2014DN06662A (ko)
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
EP3341079A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
GB2527233A (en) Composition comprising hydrocortisone
MY182818A (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
IN2013MU03317A (ko)